Polymorphisms associated with oral clefts as potential susceptibility markers for oral and breast cancer.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  R. Coletta,et al.  Potential genetic markers for nonsyndromic oral clefts in the Brazilian population: A systematic review and meta‐analysis , 2018, Birth defects research.

[3]  A. Basu,et al.  DNA Damage, Mutagenesis and Cancer , 2018, International journal of molecular sciences.

[4]  J. Hoh,et al.  GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21 , 2018, Nature Communications.

[5]  R. Coletta,et al.  Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian population , 2017, BMC Medical Genetics.

[6]  T. Beaty,et al.  Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate , 2017, Human Genetics.

[7]  J. Attia,et al.  Association between IRF6 and 8q24 polymorphisms and nonsyndromic cleft lip with or without cleft palate: Systematic review and meta‐analysis , 2016, Birth defects research. Part A, Clinical and molecular teratology.

[8]  A. Adeyemo,et al.  Association Studies and Direct DNA Sequencing Implicate Genetic Susceptibility Loci in the Etiology of Nonsyndromic Orofacial Clefts in Sub-Saharan African Populations , 2016, Journal of dental research.

[9]  O. Yalcin-Ozuysal,et al.  IRF6 Is Involved in the Regulation of Cell Proliferation and Transformation in MCF10A Cells Downstream of Notch Signaling , 2015, PloS one.

[10]  S. Hua,et al.  The roles of AXIN2 in tumorigenesis and epigenetic regulation , 2015, Familial Cancer.

[11]  A. Rana,et al.  Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression , 2015, Molecular Cancer.

[12]  Nuno A. Fonseca,et al.  Long-range enhancers regulating Myc expression are required for normal facial morphogenesis , 2014, Nature Genetics.

[13]  Meilin Wang,et al.  Three polymorphisms in IRF6 and 8q24 are associated with nonsyndromic cleft lip with or without cleft palate: Evidence from 20 studies , 2012, American journal of medical genetics. Part A.

[14]  S. Cichon,et al.  Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci , 2012, Nature Genetics.

[15]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[16]  A. R. Vieira,et al.  Risk of cancer in relatives of children born with isolated cleft lip and palate , 2012, American journal of medical genetics. Part A.

[17]  M. Passos-Bueno,et al.  Region 8q24 is a susceptibility locus for nonsyndromic oral clefting in Brazil. , 2012, Birth defects research. Part A, Clinical and molecular teratology.

[18]  A. Vieira,et al.  Family history of cleft lip and palate in subjects diagnosed with leukemia , 2012, American journal of medical genetics. Part A.

[19]  Harris Morrison,et al.  MCS9.7 enhancer activity is highly, but not completely, associated with expression of Irf6 and p63 , 2012, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  R. Ferris,et al.  Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer , 2011, Journal of dental research.

[21]  T. Beaty,et al.  Cleft lip and palate: understanding genetic and environmental influences , 2011, Nature Reviews Genetics.

[22]  E. Ratovitski.  ΔNp63α/IRF6 interplay activates NOS2 transcription and induces autophagy upon tobacco exposure. , 2011, Archives of biochemistry and biophysics.

[23]  E. Taioli,et al.  Cleft Lip and Palate in Family Members of Cancer Survivors , 2010, Cancer investigation.

[24]  Kenneth Offit,et al.  Genome-wide association studies of cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Kristel Van Steen,et al.  mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits , 2010, Bioinform..

[26]  G. Coetzee,et al.  8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC , 2010, Proceedings of the National Academy of Sciences.

[27]  Michael K. Skinner,et al.  Epigenetic transgenerational actions of environmental factors in disease etiology , 2010, Trends in Endocrinology & Metabolism.

[28]  Hongling Liao,et al.  Long-range enhancers on 8q24 regulate c-Myc , 2010, Proceedings of the National Academy of Sciences.

[29]  Joseph T. Glessner,et al.  A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. , 2009, The Journal of pediatrics.

[30]  R. Atit,et al.  Visualizing canonical Wnt signaling during mouse craniofacial development , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  P. Kantoff,et al.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression. , 2009, Cancer research.

[32]  Christopher A. Haiman,et al.  The 8q24 cancer risk variant rs6983267 demonstrates long-range interaction with MYC in colorectal cancer , 2009, Nature Genetics.

[33]  Bernhard Horsthemke,et al.  Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24 , 2009, Nature Genetics.

[34]  J. Mulliken,et al.  Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. , 2008, Human molecular genetics.

[35]  Michael T. Longaker,et al.  Chemical rescue of cleft palate and midline defects in conditional GSK-3β mice , 2007, Nature.

[36]  Xavier Estivill,et al.  SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..

[37]  M. Katoh,et al.  WNT/PCP signaling pathway and human cancer (review). , 2005, Oncology reports.

[38]  M. Hendrix,et al.  Mammary Serine Protease Inhibitor (Maspin) Binds Directly to Interferon Regulatory Factor 6 , 2005, Journal of Biological Chemistry.

[39]  M Vekemans,et al.  Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer , 2005, Journal of Medical Genetics.

[40]  Bradley P. Coe,et al.  Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer , 2004, Genes, chromosomes & cancer.

[41]  J. Olsen,et al.  Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark , 2002, British Journal of Cancer.

[42]  A. R. Vieira,et al.  IRF6 AP-2a binding site promoter polymorphism is associated with oral clefts in Latvia. , 2014, Stomatologija.

[43]  A. P. Caldeira,et al.  Risk of leukemia in first degree relatives of patients with nonsyndromic cleft lip and palate. , 2014, Brazilian oral research.

[44]  A. Ramanathan,et al.  A novel heterozygous mutation (F252Y) in exon 7 of the IRF6 gene is associated with oral squamous cell carcinomas. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[45]  M. Marazita,et al.  AXIS inhibition protein 2, orofacial clefts and a family history of cancer. , 2009, Journal of the American Dental Association.

[46]  S. Line,et al.  A simple and cost-effective protocol for DNA isolation from buccal epithelial cells. , 2007, Brazilian dental journal.